drugset / Trial / NCT00614016

A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Sodium ST20 in Healthy Volunteers

NCT00614016 ↗

Phase 1 Completed 40 enrolled HemaQuest Pharmaceuticals Inc.
RandomizedSingle-groupDouble-blind

Summary

A safety and pharmacokinetic study of a single dose of ST20 in healthy volunteers

Timeline

Start
2008-01
Primary completion
2008-04
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject ST20 Unknown — Oral

Indications

No indication recorded.